Date | release summary |
---|---|
10/2/2023 |
Updated MSD to create mappings between CVX, RxNorm and NDC: Provides more robust results by returning CVX codes alongside or in addition to RxNorm and NDC codes. These “crosswalked” mappings will appear when customers search by description within the Medication domain, and also when searching by any of the supported code sets (RxNorm, NDC, or CVX) Updated Synonyms/labels and CIRS within the lab matching logic: Provides more robust content to improve matching quality when customers send lab inputs that contain synonyms of LOINC descriptions. Additionally, this update provides customers with our most up to date clinical inductive rules (CIR) created by our clinical team, and these rules help produce more accurate matches based on the LOINC parts identified within the input term. Updated Lab matching logic to utilize the latest version of LOINC (2.76): Allows for customers to receive match results based on the latest version of LOINC content available. |
9/4/2023 |
Precision Normalize now supports ICD-O-3 within the Problem domain. With this new feature, customers can normalize input terms along with IMO, SNOMED or ICD codes within the Problem domain and receive ICD-O-3 attributes/codes for applicable IMO results. By incorporating ICD-O-3 code sets, IMO can enhance its capabilities for oncology-related clinical documentation, coding, and data analysis, leading to improved patient care, research, and interoperability. 1. These codes represent a dual classification system designed to capture a topological code and a histological code for each neoplasm. We have added new attributes in the search and detail payloads for Topography, Morphology, Histological Grading and Immunophenotype Designation. Precision Normalize has added a new flag within the Problem domain to clearly distinguish IMO lexicals that are eligible for further refinement using IMO’s modifier workflow within Core. 1. This new flag is a boolean variable indicating whether the lexical can be further refined using IMO's ICD-10-CM calculator/modifier workflow data. When true, it indicates that a term with more ICD-10-CM relevant specificity can be retrieved by submitting the lexical to the IM. |
8/21/2023 |
Normalize has added CVX Notes, MVX codes, and MVX status to the metadata when CVX codes are returned. Customers will be able to receive additional metadata in their response for CVX Notes, MVX codes, and MVX status. This will allow for easier reporting and transmission of CVX related information. |
7/24/2023 |
Continued Improvements to Medication Parser and fuzzy matching Resolved issue with missing Map_Context in the ICD-10-CM code mappings Resolved issue with Discrepancy Check not functioning properly for input_code_first preference |
6/26/2023 |
Added exact matching logic for LOINC long and short common names. Medication Parser matching improvements to include: Removed duplicate precise ingredients. Content has been updated/refreshed for the following areas: |
5/29/2023
|
Normalize engine now supports SNOMED-CT-US terminology. Medication matching has been improved to provide more accurate scoring when the input string doesn't contain ingredients and normalize returns the correct match that now includes ingredient information. In the example below, previous scored low, but now produces a higher score: |
5/15/2023
|
Normalize engine now includes full support for ICD-10-DSM terminology. This includes: |
5/1/2023 | Normalize will now limit the total number of NDC codes displayed within the output. If the matched lexical contains up to 25 NDC>RxNorm code mappings, all 25 NDC codes will display in the output. This covers approximately 82% of all RxNorm codes. If there are greater than 25 NDC code mappings, the output will display additional map context of "Maps to more than 25 NDC product codes." |
4/4/2023 | Tie breaking logic and rules have been added to provide a more consistent matching experience when a given term previously had multiple potential matches. |
3/20/2023 | Enabled Fuzzy title matching for all RxNorm synonym titles. This increases opportunities for improved string matching, and customers will likely experience an increase in True Positive match results, along with a decrease in False Positive results. |
3/6/2023 | Medication improvements to include: In an effort to create more consistent match results, we have created logic to query titles when they are tied to more than one RxCUI, and then prioritize which is returned. Indexes have been updated to expose more titles and allow for them to be searchable. This provides expanded matching capabilities and allows for customers to receive better match results. |
2/6/2023 |
Normalize has implemented two separate features to help address False Positive results caused by some RxNorm synonyms. 1. Normalize no longer returns non-drug ingredients as a match Example: If the input term was hot soapy water, we previously were returned water as the match scored at 1.0. Water is not a valid ingredient to return, as it will never be administered as a drug. We do still keep those ingredients for multi-ingredient drugs and try to match based on that scenario. |
2/1/2023 |
The lab normalize project has created a list clinical inductive rules (CIR) for most of the tests found in a Comprehensive Metabilic Panel (CMP), Complete Blood Count with Differential (CBC DIFF), a subset of COVID tests, and a few additional chemistry tests. The CIR were inserted into our lab normalize pipeline, situated primarily between the LOINC parts identifier and the LOINC code resolver with a few overriding features where needed. When the rules were applied to a known data set, it was noted that for select tests, the process was able to resolve to a single LOINC code. |
1/23/2023 |
Global transformations are now in production for the Medication domain. These transformations will allow for Normalize to better interpret abbreviated drug and chemical names that are present within input terms and improve matching results. Remediated the following issues: |